Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma

od Engesæter, Birgit, Engebraaten, Olav, Flørenes, Vivi Ann, Mælandsmo, Gunhild Mari
Wydane 2012

Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma

od Davidson, Ben, McFadden, Erin, Holth, Arild, Brunetti, Marta, Flørenes, Vivi Ann
Wydane w Virchows Arch (2020)

Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma

od Flørenes, Vivi Ann, Emilsen, Elisabeth, Dong, Hiep Phuc, Førsund, Mette, Holm, Ruth, Slipicevic, Ana
Wydane w Cancer Med (2015)

Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes

od Wang, Zhihui, Trope, Claes G, Flørenes, Vivi Ann, Suo, Zhenhe, Nesland, Jahn M, Holm, Ruth
Wydane 2010

Collateral Expression of Proangiogenic and Tumorigenic Properties in Intestinal Epithelial Cell Variants Selected for Resistance to Anoikis

od Rak, Janusz, Mitsuhashi, Yoshihiro, Sheehan, Cap, Krestow, Julia K, Florenes, Vivi Ann, Filmus, Jorge, Kerbel, Robert S
Wydane 1999

Protein Expression of the Cell-Cycle Inhibitor p27(Kip1) in Malignant Melanoma : Inverse Correlation with Disease-Free Survival

od Flørenes, Vivi Ann, Mælandsmo, Gunhild M., Kerbel, Robert S., Slingerland, Joyce M., Nesland, Jahn M., Holm, Ruth
Wydane 1998

E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27(KIP1)

od St. Croix, Brad, Sheehan, Capucine, Rak, Janusz W., Flørenes, Vivi Ann, Slingerland, Joyce M., Kerbel, Robert S.
Wydane 1998

High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy

od Magnussen, Gry Irene, Holm, Ruth, Emilsen, Elisabeth, Rosnes, Anne Katrine Ree, Slipicevic, Ana, Flørenes, Vivi Ann
Wydane 2012

High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients

od Magnussen, Gry Irene, Hellesylt, Ellen, Nesland, Jahn M, Trope, Claes G, Flørenes, Vivi Ann, Holm, Ruth
Wydane 2013

The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells

od Slipicevic, Ana, Jørgensen, Kjersti, Skrede, Martina, Rosnes, Anne Katrine Ree, Trøen, Gunhild, Davidson, Ben, Flørenes, Vivi Ann
Wydane 2008

hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma

od Fleten, Karianne G, Flørenes, Vivi Ann, Prasmickaite, Lina, Hill, Oliver, Sykora, Jaromir, Mælandsmo, Gunhild M, Engesæter, Birgit
Wydane w Cell Death Discov (2016)

Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival

od Slipicevic, Ana, Holm, Ruth, Emilsen, Elisabeth, Ree Rosnes, Anne Katrine, Welch, Danny R, Mælandsmo, Gunhild M, Flørenes, Vivi Ann
Wydane 2012

Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma

od Magnussen, Gry Irene, Emilsen, Elisabeth, Giller Fleten, Karianne, Engesæter, Birgit, Nähse-Kumpf, Viola, Fjær, Roar, Slipicevic, Ana, Flørenes, Vivi Ann
Wydane w BMC Cancer (2015)

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

od Slipicevic, Ana, Øy, Geir Frode, Rosnes, Anne Katrine Ree, Stakkestad, Øystein, Emilsen, Elisabeth, Engesæter, Birgit, Mælandsmo, Gunhild M., Flørenes, Vivi Ann
Wydane 2013

Soluble AXL as a marker of disease progression and survival in melanoma

od Flem-Karlsen, Karine, Nyakas, Marta, Farstad, Inger Nina, McFadden, Erin, Wernhoff, Patrik, Jacobsen, Kari Dolven, Flørenes, Vivi Ann, Mælandsmo, Gunhild Mari
Wydane w PLoS One (2020)

Candidate Genes for Testicular Cancer Evaluated by In Situ Protein Expression Analyses on Tissue Microarrays

od Skotheim, Rolf I, Abeler, Vera M, Nesland, Jahn M, Fosså, Sophie D, Holm, Ruth, Wagner, Urs, Flørenes, Vivi Ann, Aass, Nina, Kallioniemi, Olli P, Lothe, Ragnhild A
Wydane 2003

Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy

od Dillard, Pierre, Köksal, Hakan, Maggadottir, Solrun Melkorka, Winge-Main, Anna, Pollmann, Sylvie, Menard, Mathilde, Myhre, Marit Renée, Mælandsmo, Gunhild M., Flørenes, Vivi Ann, Gaudernack, Gustav, Kvalheim, Gunnar, Wälchli, Sébastien, Inderberg, Else Marit
Wydane w Mol Ther (2021)

MX2 is a novel regulator of cell cycle in melanoma cells

od Juraleviciute, Marina, Pozniak, Joanna, Nsengimana, Jérémie, Harland, Mark, Randerson-Moor, Juliette, Vernhoff, Patrik, Bassarova, Assia, Øy, Geir Frode, Trøen, Gunhild, Flørenes, Vivi Ann, Bishop, David Timothy, Herlyn, Meenhard, Newton-Bishop, Julia, Slipicevic, Ana
Wydane w Pigment Cell Melanoma Res (2019)

Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients

od Schaner, Marci E, Davidson, Ben, Skrede, Martina, Reich, Reuven, Flørenes, Vivi Ann, Risberg, Björn, Berner, Aasmund, Goldberg, Iris, Givant-Horwitz, Vered, Tropè, Claes G, Kristensen, Gunnar B, Nesland, Jahn M, Børresen-Dale, Anne-Lise
Wydane 2005

A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases()

od Flørenes, Vivi Ann, Flem-Karlsen, Karine, McFadden, Erin, Bergheim, Inger Riise, Nygaard, Vigdis, Nygård, Vegard, Farstad, Inger Nina, Øy, Geir Frode, Emilsen, Elisabeth, Giller-Fleten, Karianne, Ree, Anne Hansen, Flatmark, Kjersti, Gullestad, Hans Petter, Hermann, Robert, Ryder, Truls, Wernhoff, Patrik, Mælandsmo, Gunhild Mari
Wydane w Transl Oncol (2019)